Lifespan Cancer Institute at Rhode Island Hospital — Providence, Rhode Island

Lifespan Cancer Institute at Rhode Island Hospital is a clinical research site located in Providence, Rhode Island, United States 02903.

Crixeo Clinical Trials Trust Score: 95/100 (GOOD). This profile has not yet been claimed by the site owner.

Lifespan Cancer Institute at Rhode Island Hospital has participated in 5 clinical trials with 1 currently active.

Therapeutic areas: Other Cancer, Ovarian Carcinoma, Fallopian Tube Carcinoma.

Sponsors: Dana-Farber Cancer Institute, Numab Therapeutics AG, Imugene Limited.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Providence

Browse all research sites in Rhode Island · View every site in Providence

• The Miriam Hospital Clinical Research Site (TMH CRS) CRS
• Brown University Oncology Research Group
• Women & Infants Hospital /ID# 269032
• Rhode Island Hospital /ID# 151538
• VA Providence Healthcare System
• Hasbro Children's Hospital/Rhode Island Hospital
• Brown University Health - Lipid Clinic
• Department of Orthopaedic Surgery, Rhode Island Hospital
• Vascular Disease Research Center at Rhode Island Hospital
• RI Hospital
• The Weight Control and Diabetes Research Center of The Miriam Hospital & Brown University

Sponsor Feasibility Report

Trust Score: 95/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lifespan Cancer Institute at Rhode Island Hospital?

Lifespan Cancer Institute at Rhode Island Hospital has a Crixeo Trust Score of 95/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lifespan Cancer Institute at Rhode Island Hospital conducted?

Lifespan Cancer Institute at Rhode Island Hospital has 5 clinical trials on record, with 1 currently active. Their work covers Other Cancer, Ovarian Carcinoma, Fallopian Tube Carcinoma.

Is Lifespan Cancer Institute at Rhode Island Hospital accredited by Crixeo Clinical Trials?

Lifespan Cancer Institute at Rhode Island Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lifespan Cancer Institute at Rhode Island Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.